Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
about
Kinetic and structural analyses of hepatitis C virus polyprotein processingEvidence for hepatitis C viral infection in patients with primary hepatocellular carcinomaIntrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.Enzyme-linked immunosorbent assay based on a chimeric antigen bearing antigenic regions of structural proteins Erns and E2 for serodiagnosis of classical swine fever virus infectionAntigenic structure of the hepatitis C virus envelope 2 proteinImproved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting systemSubstrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinaseAn amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4AActivity of purified hepatitis C virus protease NS3 on peptide substratesChimeric Sindbis viruses dependent on the NS3 protease of hepatitis C virusCharacterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoiresMemory CD8+ T cells are required for protection from persistent hepatitis C virus infectionBoth NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteinsNonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctionsA unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variantsCharacterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia virusesEarly detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragmentVirological features of hepatitis C virus infection in hemodialysis patientsA quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cellsPrevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralizationVaccination of chimpanzees against infection by the hepatitis C virusUse of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.Experimental and emerging therapies for chronic hepatitis C virus infection.Affinity labeling of hepatitis C virus replicase with a nucleotide analogue: identification of binding site.Hepatitis C virus non-structural protein 3 interacts with cytosolic 5'(3')-deoxyribonucleotidase and partially inhibits its activity.Improving antigenicity of the recombinant hepatitis C virus core protein via random mutagenesisRapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections.Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.Hepatitis C: progress and problems.Staufen1 promotes HCV replication by inhibiting protein kinase R and transporting viral RNA to the site of translation and replication in the cells.Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.Molecular detection of hepatitis C virus: impact of detection methodology on clinical and laboratory correlations.Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells.Laboratory diagnosis of hepatitis C.Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.Role of signal-to-cutoff ratios in hepatitis C virus antibody detection.Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C.
P2860
Q24648164-04C1C6CB-5EFD-489D-B812-0A3DDEFC2EB5Q27469317-37CE8FFC-0E28-499A-847E-146EF55A0AB1Q27469851-09899FBB-3B3E-4606-84A6-82111F52D97FQ27470350-310F2B7B-9ECE-40B0-AE16-6357CAA8F01DQ27473441-C6649D60-F724-4E74-A1E2-D85F009E3C37Q27477788-DAEDC981-3500-49A2-9182-929B2E764FD6Q27478443-B63BDB27-B914-4610-B1E4-9769A914B9CFQ27478459-0A85E2FF-5E41-4996-A9B8-C0B377A58660Q27480741-399D9F13-6213-4123-B7A0-68406069B50DQ27480780-5E489827-AA95-43DD-99AB-46476FC29827Q27480876-5563C5BE-3AB9-4CCF-8B4A-E0EBA597F543Q27485119-4EDF190D-93B3-4836-BD02-016CB2660F0BQ27485988-299B52C3-559E-471A-AEA9-0FC3C6F0177FQ27486051-69336822-ABF1-4D73-9FBC-B8291C31DB59Q27486061-B9BAB0C8-7B72-4C54-9C0D-724E91100CA8Q27486074-3801824E-A5C3-4E91-8703-2D41011D22F1Q27487886-0DC57667-6BDF-41C0-A9E5-725BF3A741C0Q27488263-87DF023A-0348-498B-9758-E68BF3F14833Q29615897-F3AD4053-02F9-4A45-9F2C-B5A0C25C8DDAQ29615898-C8ADF2B0-BEDF-4388-AEAD-F7E5E62E9B1AQ29615899-59AA1EFE-9C68-485B-B1EB-8E83F90789EFQ33960150-44B62AFD-8C04-4EED-8CEB-8EB577195975Q34481629-008D5B88-C43E-46D3-B747-4570033E9865Q34523107-39DF0F2C-F0FE-4256-A432-76B42DE367AEQ34850816-CAC6EF91-FF5B-4FB3-9540-640C9EB8D70EQ35195130-FC5FE2DA-460D-4511-ACAE-7170E8141B65Q35273404-4279A3A5-4C85-44A2-AAB5-BE2164DD3575Q35872114-B3C478A5-D50A-4BBD-9219-0E3F2E452777Q36636890-33848366-5209-46F0-A526-6AC865808657Q36642065-0FE74816-8416-4063-B296-9C73F5C268A3Q37021569-15974770-C8FF-450E-AC16-F31FA654EA45Q38738857-3A7D2F19-BF64-485B-8705-760CFEED6CC4Q40524352-CF90CEB9-78B3-4176-8F9D-810855C1A7EDQ40672442-44C2CD65-E48C-4AC0-AE2E-81E113F0FDA2Q40756784-49CC63B4-3FBC-472E-845E-D5F4FCE4301FQ41351271-5BAE8276-C70E-48B4-A8E3-03C29C9FBA3CQ41785165-CAF277EA-7736-4168-8CF3-D08D0CD21D49Q41863610-F586D19C-9DEC-4339-90F2-E1B0CBB92BBEQ42980848-5DC9E9BA-8D84-4661-9379-F945152D4562Q42981859-150AEC63-7E40-4C8D-9E75-01CC27373E46
P2860
Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Diagnosis of hepatitis C virus ...... role of HCV in liver disease.
@en
Diagnosis of hepatitis C virus
@nl
type
label
Diagnosis of hepatitis C virus ...... role of HCV in liver disease.
@en
Diagnosis of hepatitis C virus
@nl
prefLabel
Diagnosis of hepatitis C virus ...... role of HCV in liver disease.
@en
Diagnosis of hepatitis C virus
@nl
P2093
P2860
P356
P1476
Diagnosis of hepatitis C virus ...... role of HCV in liver disease.
@en
P2093
McFarland J
Shuster JR
P2860
P304
10011-10015
P356
10.1073/PNAS.89.21.10011
P407
P577
1992-11-01T00:00:00Z